AIDIT and IMPACT: Building research collaborations in targeted prostate cancer screening

Journal of B.U.ON.

Volumn 11, Issue 4, 2006, Pages 415-418

  Doherty, R ^a   Lubinski, J ^b   Manguoglu, E ^c   Luleci, G ^c   Christie, M ^a   Craven, P ^a   Bancroft, E ^d   Mitra, A ^a   Morgan, S ^a   Eeles, Rosalind ^a,d  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b POMERANIAN MEDICAL UNIVERSITY   (Poland)

^c AKDENIZ UNIVERSITY   (Turkey)

^d INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

BRCA1; BRCA2; Prostate cancer; Targeted screening

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; PROSTATE SPECIFIC ANTIGEN;

ARTICLE; CANCER DIAGNOSIS; CANCER RESEARCH; CANCER SCREENING; CANCER SUSCEPTIBILITY; EUROPE; GENETIC RISK; HUMAN; MALE; MEDICAL SOCIETY; ONCOGENE; PROSTATE CANCER; BLOOD; COOPERATION; GENETIC PREDISPOSITION; GENETICS; INTERNATIONAL COOPERATION; MASS SCREENING; MEDICAL RESEARCH; PROSTATE TUMOR; REVIEW;

BIOMEDICAL RESEARCH; BRCA1 PROTEIN; BRCA2 PROTEIN; COOPERATIVE BEHAVIOR; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERNATIONAL COOPERATION; MALE; MASS SCREENING; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS;

EID: 33947541239     PISSN: 11070625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Boyle P, Ferlay J. Cancer incidence and mortality in Europe, 2004. Ann Oncol 2005; 16: 481-488.
2. Commission of the European Communities. Communication from the Commission to the Council, the European Parliament, the Economic and Social Committee and the Committee of the Regions: Towards a European Research Area. COM 2000, 6.
3. Baranes E, Gassot Y. Interview with Philippe Busquin, European Commissioner for Research. Communications Strategies 2002; 48: 15-23.
4. Steinberg GD, Carter BS, Beaty TH, Childs B, Walsh PC. Family history and the risk of prostate cancer. Prostate 1990; 17: 337-347.
5. Tulinius H, Egilsson V, Olafsdottir GH, Sigvaldason H. Risk of prostate, ovarian, and endometrial cancer among relatives of women with breast cancer. Br Med J 1992; 305: 855-857.
6. Thompson D, Easton DF, Breast Cancer Linkage Consortium. Cancer Incidence in BRCA1 mutation carriers. J Natl Cancer Inst 2002; 94: 1358-1365.
7. Thompson D, Easton D. Breast Cancer Linkage Consortium. Variation in cancer risks, by mutation position, in BRCA2 mutation carriers. Am J Hum Genet 2001; 68: 410-419.
8. Schroder FH, Bangma CH. The European Randomized Study of Screening for Prostate Cancer (ERSPC). Br J Urol 1997; 79 (Suppl 1): 68-71.
9. De Koning HJ, Auvinen A, Berenguer Sanchez A et al. Large-scale randomized prostate cancer screening trials: program performances in the European Randomized Screening for Prostate Cancer trial and the Prostate, Lung, Colorectal and Ovary cancer trial. Int J Cancer 2002; 97: 237-244.
10. Antoniou AC, Pharoah PD, McMullan G et al. A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes. Br J Cancer 2002; 86: 76-83.